These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 886321)

  • 1. Rapid post mortem changes in 3,4-dihydroxyphenylacetic acid (DOPAC), a dopamine metabolite, in rat striatum.
    Moleman P; Bruinvels J; Westerink BH
    J Neurochem; 1977 Jul; 29(1):175-7. PubMed ID: 886321
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo voltammetric determination of the kinetics of dopamine metabolism in the rat.
    Michael AC; Justice JB; Neill DB
    Neurosci Lett; 1985 May; 56(3):365-9. PubMed ID: 4022449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does brain 3,4-dihydroxyphenylacetic acid reflect dopamine release?
    Soares-da-Silva P
    J Pharm Pharmacol; 1987 Feb; 39(2):127-9. PubMed ID: 2881997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) content in mice.
    Saitoh T; Mizuno Y; Nagatsu T; Yoshida M
    Neurosci Lett; 1988 Oct; 92(3):321-4. PubMed ID: 3200488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of LSD and 2-bromo LSD on striatal DOPAC levels.
    Persson SA
    Life Sci; 1977 Apr; 20(7):1199-205. PubMed ID: 15175
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo dialysis measurements of dopamine and DOPAC in rats trained to turn on a circular treadmill.
    Sabol KE; Richards JB; Freed CR
    Pharmacol Biochem Behav; 1990 May; 36(1):21-8. PubMed ID: 2349264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of 3,4-dihydroxyphenylacetic acid and 3-methoxytyramine specific activity rat striatum.
    Di Giulio AM; Groppetti A; Algeri S; Ponzio F; Cattabeni F; Galli CL
    Anal Biochem; 1979 Jan; 92(1):82-90. PubMed ID: 426290
    [No Abstract]   [Full Text] [Related]  

  • 8. Probenecid increases dopamine metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in rat adrenal gland.
    Kawaguchi A; Niwa M; Ozaki M
    Jpn J Pharmacol; 1983 Jun; 33(3):611-7. PubMed ID: 6620731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopaminergic antagonists on striatal DOPAC concentrations and alpha-methyl-p-tyrosine-induced decline of dopamine following intrastriatal injections of kainic acid.
    Wuerthele SM; Moore KE
    J Pharm Pharmacol; 1979 Mar; 31(3):180-2. PubMed ID: 34696
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of morphine to increase striatal 3,4-dihydroxyphenylacetic acid in fasted rats.
    De Montis GM; Olianas MC; Di Lorenzo C; Tagliamonte A
    Eur J Pharmacol; 1978 Jan; 47(1):121-3. PubMed ID: 618726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of probenecid on endogenous and exogenous 3,4-dihydroxyphenylacetic acid and homovanillic acid in the rat brain.
    Broch OJ
    Eur J Pharmacol; 1976 Sep; 39(1):33-40. PubMed ID: 964303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent on-line analysis of striatal ascorbate, dopamine and dihydroxyphenylacetic acid concentrations by in vivo voltammetry.
    Gonzalez-Mora JL; Sanchez-Bruno JA; Mas M
    Neurosci Lett; 1988 Mar; 86(1):61-6. PubMed ID: 3362430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroxyphenylacetic acid conjugate: natural occurrence and demonstration of probenecid-induced accumulation in rat striatum, olfactory tubercles and frontal cortex.
    Elchisak MA; Maas JW; Roth RH
    Eur J Pharmacol; 1977 Feb; 41(4):369-78. PubMed ID: 844481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute choline administration in rat and mouse: no effect on dopamine metabolism in brain.
    Flentge F; Postema F; Medema HM; Van den Berg CJ
    Life Sci; 1981 Jul; 29(4):331-5. PubMed ID: 7278490
    [No Abstract]   [Full Text] [Related]  

  • 16. Modifications of DOPAC levels in the striatum and olfactory tubercles of the rat after muscimol.
    Restelli A; Zambotti F; Vicentini L; Zonta N; Mantegazza P
    Pharmacol Res Commun; 1979 Jan; 11(1):55-9. PubMed ID: 424439
    [No Abstract]   [Full Text] [Related]  

  • 17. Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.
    Roth RH; Murrin LC; Walters JR
    Eur J Pharmacol; 1976 Mar; 36(1):163-71. PubMed ID: 177297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-serotonergic [3H]ketanserin binding sites in striatal membranes are associated with a dopac release system on dopaminergic nerve endings.
    Leysen JE; Eens A; Gommeren W; Van Gompel P; Wynants J; Janssen PA
    Eur J Pharmacol; 1987 Feb; 134(3):373-5. PubMed ID: 3569421
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass fragmentography.
    Wiesel FA; Sedvall G
    Brain Res; 1974 Jan; 65(3):547-50. PubMed ID: 4415145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.